Professional Documents
Culture Documents
A septic (infected) knee is most often caused by bacteria (such as staph or strep), but in rare instances can be caused by other microorganisms. Prompt diagnosis and treatment is essential in the native knee to avoid rapid destruction of the cartilage and bone in the knee. When diagnosed early, treatment is usually arthroscopic irrigation and debridement. However, an open debridement may be required. Despite early diagnosis and treatment, joint destruction may still occur. Late effects of joint infection (septic arthritis) may require treatment with joint replacement as long as there is no persistent infection remaining within the knee. While joint infection occasionally affects people with no known predisposing risk factors, it more commonly occurs when certain risk situations are present. Risks for the development of septic arthritis include diabetic patient, trauma such as injury or wound, bacteria/microorganism, drug use, alcoholism, kidney dialysis, malnutrition, advanced age, orthopaedic surgery Signs and Symptoms of Septic Arthritis include bone pain, swelling and redness of the skin, fatigue, general discomfort or ill feeling and drainage of pus through the skin.
II. PATIENTS PROFILE Name: Patient X Address: #52 2nd West Crame, Brgy. San Juan, San Juan City Date Admitted: May 31, 2011 Admitting Diagnosis: Septic knee, ankle, 1st MT right foot Principal Diagnosis: Septic knee, ankle, 1st MT right foot Chief Complaint: Swelling right knee, ankle and foot Principal Operation Procedure: Aspiration of knee, ankle, MT right foot III. PATIENT HISTORY Case Study: Septic Knee, Ankle, 1st MT Right Foot
Socioenomic History
Patient X was on his 4th grade. Both parents are deceased due to vehicular accident, there were six in the family and he was the youngest, their auntie is the one who support their needs, work as a Brgy. Health Worker with the monthly income of P3,000.
IV. ANATOMY AND PHYSIOLOGY The knee joint joins the thigh with the leg and consists of two articulations: one between thefemur and tibia, and one between the femur and patella. It is the largest joint in the human body and is very complicated. The knee is a mobile trocho-ginglymus (i.e. a pivotal hinge joint), which permits flexion and extension as well as a slight medial and lateral rotation. Since in humans the knee supports nearly the whole weight of the body, it is vulnerable to both acute injury and the development of osteoarthritis. The ankle joint is formed where the foot and the leg meet. The ankle, ortalocrural joint, is a synovial hinge joint that connects the distal ends of the tibia and fibulain the lower limb with the proximal end of the talus bone in the foot. The articulation between the tibia and the talus bears more weight than between the smaller fibula and the talus. The metatarsus or metatarsal bones are a group of five long bones in the foot located between the tarsal bones of the hind- and mid-foot and the phalanges of the toes. Lacking individual names, the metatarsal bones are numbered from the medial side (side of big toe): the first, second, third, fourth, and fifth metatarsal. The metatarsals are analogous to themetacarpal bones of the hand.
Normal Abnormal
V. PATHOPHYSIOLOGY Predisposing factors: Modifiable: Compromised Immune system Invasive procedures (catheter insertion, etc.) Unsafe sex IV drug abuse Bacterial infections already present in the body Trauma Non Modifiable: Age extremes Trauma
ove
Manipulation
Tissue damage
Exposure of joints
Hematogenous spread Case Study: Septic Knee, Ankle, 1st MT Right Foot
Potts Disease Risk Factor : Poor Environmental Sanitation, Living in a congested area, Trauma: Fall
Lungs
Circulation
the infection spread to the two adjacent vertebrae into the adjoining disk space
mycobacterium tubercle bacilli spread into the thoracic vertebra of the spine
Procedure
1. Monitor Temperature 2. Monitor Pulse Rate 3. Monitor Respiration Rate 4. Monitor Apical Pulse Rate 5. Skin 6. Hair 7. Eyes 8. External Ear 9. Internal Ear 10. External Nose 11. Sinuses 12. Lips 13. Tongue 14. Gums 15. Teeth
Technique
Using thermometer Palpation Observation Auscultation Inspection Inspection Inspection Inspection Inspection Inspection Palpation Inspection Inspection Inspection Inspection
Normal Findings
35.6-37.7 C 70-100 BPM 20-28 BPM 60-100 BPM Pink, smooth, turgor present Lustrous and shiny Clear, moist surfaces, transparent cornea Non-tender auricle, tragus Free from any discharge Color same as face, smooth and symmetrical appearance Non-tender upon palpation Pink, smooth, moist Deep red with papillae Smooth, firm, pink Straight with no cavities
Actual Findings
Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal With missing upper central and lateral incisor Normal
Interpretation
Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Abnormal
Analysis
Not related to the case, the patient was at his deciduous teeth extraction
16. Neck
Inspection
17. Thyroid
Inspection/Palpation
Smooth, controlled movements, ROM flexion 45 , extension 55 , lateral abduction 40 , rotation 70 Midline, smooth, firm, non-
Normal
Normal
Normal
18. Trachea 19. Abdomen 20. Umbilicus 21. Bowel Sounds 22. Extremities 23. Nails 24. Peripheral Pulses 25. Carotid Arteries 26. Temporal Arteries 27. ROM -Cervical Spine -Elbow -Wrist
Inspection Inspection Inspection Auscultation Inspection Inspection Palpation Palpation Palpation Inspection/Observation Inspection/Observation Inspection/Observation
tender Midline position, symmetrical, landmarks identifiable Rounded or flat Sunken, centrally located 2 or 3 times/minute Fair color over the body, warm to touch Pinkish nail beds. Nail firm Bilateral pulses strong and equal Palpable, equal and strong Palpable, equal and strong Flexion/extension 45 Lateral Bending 40 Flexion 160 Extension 180 Pronation/Supination 90 Flexion/Hypertension 90 Ulnar deviation 55 Radial deviation 20 Flexion 90 Hyperextension 20 Dorsiflexion 20
Normal Normal Protrude Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Normal Limited ROM
Normal Normal Abnormal Normal Normal Normal Normal Normal Normal Normal Case Study: Septic Knee, Ankle, 1st MT Right Foot Normal Normal Normal Normal Normal Normal Normal Normal Abnormal Poor nutritional status
-Fingers -Ankles
Inspection/Observation Inspection/Observation
Plantar flexion 45
Limited ROM
Abnormal
Due to accumulation of microorganism in the area, swelling occurs thus causing pain when moving Due to accumulation of
Eversion 20
Limited ROM
Abnormal
Inversion 30
Limited ROM
Abnormal
Abduction 10
Limited ROM
Abnormal
Adduction 20
Limited ROM
Abnormal
microorganism in the area, swelling occurs thus causing pain when moving Due to accumulation of microorganism in the area, swelling occurs thus causing pain when moving Due to accumulation of microorganism in the area, swelling occurs thus causing pain when moving Due to accumulation of microorganism in the area, swelling occurs thus causing pain when moving Due to accumulation of microorganism in the area, swelling occurs thus causing pain when moving
Test Name
Actual Findings
May 31, 2011 71 0.23 11.50 0.38 0.51 0.06 0.05 688 70 22 31 40.58 U/L 34.34 U/L August 3, 2011 CS: No growth after 72 hours of incubation GS: RBC: +++, WBC; few gram (+) cocci seen singly; No spore-forming bacilli seen August 31, 2011 92 0.28 8.80 0.21 0.64 0.08 0.07 511 82 27 33
Normal Findings
Interpretation
May 31 August 31 Low Low Normal Normal Normal High High High Normal Low
Hematology
<37. 00 U/L <42.00 U/L No growth and free from any kind of microorganisms and/or bacteria
To determine drugs effect taken by the patient thus causing cholestasis and other hepato toxicity. To identify the bacteria or fungi that normally populate in the patients wound.
Hemoglobin Mass Hematocrit Leukocyte Differential Count Lymphocytes Segmenters Monocytes Eosinophils Platelet Count Indices MCV MCH MCHC
127-183 g/L 0.37-0.54 4.5 - 10 x 10 9/L 0.20-0.40 0.50-0.70 0.00-0.07 0.00-0.05 150-400 x 10 g/L 82-92 fl 28-32 pg 32-38 %
Low Low High Normal Normal Normal Normal High Low Low Low
Chest X-ray
Management
Medication
Focus
Antibiotic Therapy Anti-tuberculosis drugs NSAIDS High calorie, High protein, High calcium diet
Nutrition
Exercise
10
June 3, 2011 CS: No growth after 72 hours of incubation GS: a.) RBC: few; no microorganism seen; No spore-forming bacilli seen b.) RBC: few; WBC: rare; No microorganism seen; No spore-forming bacilli seen; No acid fast bacilli seen. -lung marking are prominent -some enlarged hilar and transbronchial lymphodes are noted -heart is not enlarged -diaphragm and sulci are intact Impression: Findings may relate to primary Kochs infection.
A normal chest x ray will show normal structures for the age and medical history of the patient.
To evaluate organs and structures within the chest for symptoms of disease. To determine the extent of microorganism to this part.
Blood transfusion
PRBC, FWB
Procedures Name
Arthrotomy and Debridement
Actual Finding
The specimen consists of several, irregular, pale red to tan-brown, soft tissue fragments with an aggregate measurement of 5x4x1.5 m and labeled as intracapsular. Received specimen in a vial containing yellow, blood tinged fluid with clots, approximately 8.0 ml in volume
11
X. DRUG STUDY
Generic Name
Ibuprofen
Brand Name
Advil
Action
Unknown. May inhibit prostaglandin synthesis, to produce antiinflammatory, analgesic, and antipyretic effects.
Indication
Ibuprofen contains the active ingredient ibuprofen, which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of various chemicals in the body, some of which are known as prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause pain, swelling and inflammation. Ibuprofen is therefore used to relieve pain and inflammation. All the medicines in this group (NSAIDs) reduce inflammation caused by the body's own immune system, and are effective pain killers. Ibuprofen can be used to relieve pain such as muscular aches and pains, period pains, headache, backache, rheumatic
Nursing Considerations
-Tell patient to take with meals or milk to reduce adverse GI reactions. -Note: Drug is available at OTC. Instruct patient not to exceed 1.2 g daily, not to give to chidren younger than age 12, and not to take for extended periods ( longer than 3 days for fever or longer than 10 days for pain) without consulting presciber. -Tell patient that full therapeutic effect for arthritis may be delayed for 2 to 4 weeks. Although pain relief occurs at low dosage levels, inflammation doesnt improve at dosages less than 400 mg q.i.d. -Teach patient to watch for and report to prescriber immediately signs and symptoms of GI bleeding, including blood in vomit, urine, or stool or coffee ground vomit, and black, tarry stool. -Warn patient to avoid
CV
EENT GI
Tinnitus Epigastric distress, nausea, occult blood loss, peptic ulceration, diarrhea, constipation, abdominal pain, bloating, GI fullness, dyspepsia, flatulence, heartburn, decreased appetite.
GU
HEMATOLOGIC
Plonged bleeding time, anemia, neutropenia, pancytopenia, thrombocytopenia, aplastic anemia, leucopenia, agranulocystocis.
METABOLIC
12
pain, dental pain and neuralgia. It can also reduce feverishness and the symptoms of colds and flu.
Hypoglycemia, hyperkalemia.
RESPIRATORY
Bronchospasm
SKIN
Isoniazid
Niazid
-yellow skin or eyes; -dark urine; -numbness or tingling in your hands or feet; -seizures; -blurred vision; or -confusion behavior. or abnormal
13
The mechanism of action of INH is not known, but it is thought to work through its effects on lipids (fats) and DNA within the tuberculosis bacterium. It is very selective for the tuberculosis bacteria, that is, it has few if any effects on other bacteria.
INH is used to prevent active tuberculosis in persons who have an abnormal skin test for tuberculosis or in combination with other drugs for the treatment of active tuberculosis. Prophylaxis in specific patients who are tuberculin reactors (positive Mantoux test)) or who are considered to be high risk for TB.
Pruritus, rash, urticaria, stevens Johnson syndrome. -allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); -unusual fatigue; weakness or
hazardous activities that require mental alertness until effects on CNS are known. -Advise patient to wear sunscreen to avoid hypersensitivity to sunlight. Health teachings: -Take this drug in single daily dose. -Take drug on an empty stomach, 1 hour before or 2 hours after meals. If GI distress occurs, may be taken with food. -Take this drug regularly, avoid missing doses, do not discontinue without first consulting your health care provider. -Do not drink alcohol or drink as little as possible. There is an inc. risk of heap if these two drugs are combined. -Avoid foods containing tyramine, consult a dietitian to obtain a list of foods containing tyramine or histamine. -Have periodic medical check-ups, including an eye examination and blood test, to evaluate the drug
effects. -Report for weakness, fatigue, loss of appetite, n/v, yellowing of skin or eyes, darkening of the urine, numbness or tingling in hands or feet,
14
Rifampin
Rifadin
15
Treatment of Pulmonary TB in conjunction with at least one other effective antituberculotic. Neisseria meningitidis carriers, for asymptomatic carriers to eliminate meningococci from nasopharynx; not for treatment of meningitis. Unlabeled uses: Infections caused by Staphylococcus aureus and Staphylococcus epidermis, usually in combination therapy; gramnegative bacteremia in infancy; Legionella pneumophilia, not responsive to erythromycin; leprosy (in combination with dapsone); prophylaxis of meningitis caused by Haemophilis influenzae.
CNS: headache, drowsiness, fatigue, dizziness, inability to concentrate, mental confusion, generalized numbness, muscle weakness, visual disturbances. Dermatologic: Rash, pruritus, urticaria, flushing, reddish discoloration of body fluidstears, saliva, urine, sweat, sputum. GI: heartburn, distress, anorexia, vomiting gas, cramps, diaarhea, hepatitis, pancreatitis. GU: hemoglobinuria, hematuria, renal insufficiency, acute renal failure, menstrual disturbances. Hematologic: eosinophilia, thrombocytopenia, transient leucopenia, hemolytic anemia, decreased Hgb, hemolysis. Other: pain in extremities, osteomalacia, myopathy, fever, flulike symptoms.
-Teach client to take drug in a single daily dose. Take on an empty stomach, 1 hr before or 2 hrs after meals. -Inform client to take this drug regularly; avoid missing any doses; do not discontinue this drug without consulting the health care provider. -Tell client to have periodic medical checkups, including eye examinations and blood test, to evaluate the drug effects. -Inform client that he may experience the drugs side effects (especially the red colored secretion) -Instruct client to see his physician if he experience fever, chills, muscle and bone pain, excessive tiredness or weakness, loss of appetite, N/V, yellowing of eyes/skin, unusual bleeding or bruising, skin rash or itching. -Instruct client to remove contact lenses as they may discolor
Other: Mild arthralgia and myalgia have been reported frequently. Hypersensitivity reactions including rashes, urticaria, and pruritis have been reported. Fever, acne, photosensitivity, porphyria, dysuria and interstitial nephritis have been reported rarely.
16
Pyrazinamide Pyrazinamide Pyrazinamide may be bacteriostatic or bactericidal against Mycobacterium tuberculosis depending on the concentration of the drug attained at the site of infection. The mechanism of action is unknown. In vitro and in vivo the drug is active only at a slightly acidic pH.
Pyrazinamide is indicated for the initial treatment of active tubercuIosis in adults and children when combined with other antituberculous agents. (The current recommendation of the CDC for drugsusceptible disease is to use a six-month regimen for initial treatment of active tuberculosis, consisting of isoniazid, rifampin and pyrazinamide given for 2 months, followed by isoniazid and rifampin for 4 months.*4) (Patients with drug-resistant disease should be treated with regimens individualized to their situation. Pyrazinamide frequently will be an important component of such therapy.) (In patients with concomitant HIV infection, the physician should be aware of current recommendation of CDC. It is possible these patients may require a longer course of treatment.)
General: Fever, porphyria and dysuria have rarely been reported. Gastrointestinal: The principal adverse effect is a hepatic reaction (see WARNINGS). Hepatotoxicity appears to be dose related, and may appear at any time during therapy. Gl disturbances including nausea, vomiting and anorexia have also been reported. Hematologic and Lymphatic: Thrombocytopenia and sideroblastic anemia with erythroid hyperplasia, vacuolation of erythrocytes and increased serum iron concentration have occurred rarely with this drug. Adverse effects on blood clotting mechanisms have also been rarely reported.
-Take this drug in single daily dose. -Take drug on an empty stomach, 1 hour before or 2 hours after meals. If GI distress occurs, may be taken with food. -Take this drug regularly, avoid missing doses, do not discontinue without first consulting your health care provider. -Do not drink alcohol or drink as little as possible. There is an inc. risk of heap if these two drugs are combined.
Vitamin B complex
A coenzyme that stimulate metabolic function and is needed for cell replication, hematopoiesis, and nucleoprotein and myelin synthesis
This product is a combination of B vitamins used to treat or prevent vitamin deficiency due to poor diet, certain illnesses, alcoholism, or during pregnancy. Vitamins are important building blocks of the body and help keep you in good health. B vitamins include thiamine, riboflavin, niacin/niacinamide, vitamin B6, vitamin B12, folic acid, and pantothenic acid
17
CV: Peripheral vascular thrombosis, heart failure. GI: transient diarrhea. Respi: pulmonary edema. Skin: it ching, transitory exanthema, urticaria. Other: anaphylaxis, anaphylactoid reactions with parenteral administration , pain or burning at injection site
BEFORE: ~ Determine reticulocyte count, hct, Vit.B12, iron, folate levels before beginning therapy. ~ Obtain a sensitivity test history before administration ~ Avoid I.V. administration bec. faster systemic elimination will reduce effectiveness of vitamin. DURING: ~ Dont give large doses of vitaminB12 routinely; drug is lost through excretion. ~ Dont mix parenteral preparation in same syringe with other drugs. AFTER: ~ Protect Vit.B12 from light. Dont refrigerate or freeze. ~ Monitor patient for hypokalemia for first 48 hours, as anemia correct itself. Give potassium supplements, as needed
XI. NURSING CARE PLAN Assessment Subjective: Kaya ko po umupo pero di ko po kayang tumayo at lumakad Objective: Limited range of motion Limited ability to perform gross or fine motor skills Postural instability Diagnosis Impaired physical mobility related to decreased muscle strength or control as manifested by limited range of motion; limited ability to perform fine motor skills and postural instability. Planning Short term: After 4 hours of rendering nursing intervention the patient will be able to; Improve limited range of motion. Improve postural instability. Intervention Establish rapport to the patient. Assess patients condition. Determine diagnosis that contributes to immobility Assist patient to perform range of motion exercises Use assistive devices ( crutches, walkers, overhead trapeze) Provide patient with ample time to perform mobility-related tasks. Encourage the support of significant others. Rationale To gain trust and active participatio n. To be aware of the patients condition and feeling. To obtain baseline data. To prevent muscle contracture . To promote independen t movement and support. Evaluation After 4 hours of rendering nursing intervention the patient will now be able to improved range of motion and postural instability.
The patient will be able to; Maintain maximum physical mobility. Perform physical activity independently or with assisted devices.
Vital signs taken as follows: Temp: 36.9C PR: 78 BPM RR: 21 BPM Apical: 70 BPM
18
Long term:
Allow them to assist with range of motion exercises and positioning if desired. Evaluation Short term: Patient gained weight of 1 kilogram from 20.4kg to 21.4 kg. Long term: Clients condition of electrolytes and blood counts are within normal and demonstrate a Case Study: Septic Knee, Ankle, 1st MT Right Foot
Assessment Subjective: Puro cup noodles lang ang kinakain niya. As verbalized by the patients relative. Objective:
Diagnosis Risk for Imbalance Nutrition Less than body Requirements related to decrease absorption of nutrients as evidenced by poor skin turgor and weight loss.
Planning Short term: Patient will gain weight at least 1 kilogram for the next 2 weeks. Long term: Client will exhibit no signs or symptoms of malnutrition by
Intervention Establish rapport to the patient. Assess the patients weight. Determine the patients nutritional history. Determine the
Rationale To gain trust and active participation. To obtain baseline data. To assess the usual food that he eats even before he became ill. Psychological
19
patients attitude towards eating. Encourage to eat nutritious foods( High protein, high calorie & high calcium diet). Ensure that client receives small, frequent feedings. Maintain adequate hydration, increase fluid intake. Administer vitamin and mineral supplements, as ordered by physician.
factor towards eating may affect appetite and to know his eating habits. To achieve normal body weight and calcification of bone. Large amount of foods may be intolerable, to the client. To prevent dehydration & maintain hydration status. This will help as an additional to the nutritional status of the client.
20
assessment and recommendati ons regarding food preferences and nutritional support
value of foods and may be helpful in assessing specific ethnic or cultural foods.
21